about
The Escherichia coli proteome: past, present, and future prospectsExpressionview: visualization of quantitative trait loci and gene-expression data in EnsemblNpr2, yeast homolog of the human tumor suppressor NPRL2, is a target of Grr1 required for adaptation to growth on diverse nitrogen sources.The SBF- and MBF-associated protein Msa1 is required for proper timing of G1-specific transcription in Saccharomyces cerevisiae.Omics-based identification of biomarkers for nasopharyngeal carcinomaNeuroproteomics in neurotraumaPhthalic acid chemical probes synthesized for protein-protein interaction analysisSmall changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and diseaseProteomic analysis of signaling network regulation in renal cell carcinomas with differential hypoxia-inducible factor-2α expressionCharacterization of global yeast quantitative proteome data generated from the wild-type and glucose repression saccharomyces cerevisiae strains: the comparison of two quantitative methodsQualitative and quantitative characterization of plasma proteins when incorporating traveling wave ion mobility into a liquid chromatography-mass spectrometry workflow for biomarker discovery: use of product ion quantitation as an alternative data aMultidimensional Separation Using HILIC and SCX Pre-fractionation for RP LC-MS/MS Platform with Automated Exclusion List-based MS Data Acquisition with Increased Protein Quantification.Improving protein identification sensitivity by combining MS and MS/MS information for shotgun proteomics using LTQ-Orbitrap high mass accuracy data.Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection.Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.A perspective on protein profiling of blood.Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI-D20) with high metastasis potential.Combining low and high mass ion accumulation for enhancing shotgun proteome analysis by accurate mass measurementBiomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation.Mass defect labeling of cysteine for improving peptide assignment in shotgun proteomic analyses.Radiation-guided gene therapy of cancer.An insight into high-resolution mass-spectrometry data.CE-TOF MS analysis of complex protein hydrolyzates from genetically modified soybeans--a tool for foodomics.Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling.Mof-associated complexes have overlapping and unique roles in regulating pluripotency in embryonic stem cells and during differentiation.Fast proteomic protocol for biomarker fingerprinting in cancerous cells.Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in parkinson's disease.Enzymes and related proteins as cancer biomarkers: a proteomic approach.The lethal cargo of Myxococcus xanthus outer membrane vesiclesIdentification of a conserved F-box protein 6 interactor essential for endocytosis and cytokinesis in fission yeastShotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cellsGenomics, proteomics and bioinformatics of human heart failure.Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's diseaseHuman serum proteome analysis: new source of markers in metabolic disorders.Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT)Diatom proteomics reveals unique acclimation strategies to mitigate Fe limitationPharmacoproteomics in drug development.Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology.Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.
P2860
Q24549215-0F2A8BC8-A4B1-449C-A7B5-F984AFFC7E39Q24793411-F203617B-F9A6-4257-9D0B-A182756E742CQ27929831-36FAA8A9-3773-4710-AF93-60CC87763660Q27930483-95566997-D06B-4F82-BE64-3F8727CE9A4DQ28082480-C82152BF-B9B9-434E-AE55-BA4797862B3FQ28299064-A9BB1E52-0BC3-4A9F-9399-946EC1C4DE25Q28387205-856EC9A8-A9B0-410D-ADFE-5784D55C3CE1Q28396109-FE3D0E2C-7532-4AB1-BD6F-C28B9059C994Q28535086-662B7990-8F52-4282-B377-950B6E882FEEQ30491950-7AC8C0B7-DD88-44CB-A8BC-0C306A892D96Q30727415-71D13ED0-081B-4A52-A3B9-4453CF80FBC7Q31039634-EFC5C25B-C126-4777-9C3C-2EFC45297687Q31146667-EBC1482B-8D8A-4437-B346-DBA97073B54FQ33204056-3EEC1102-92C9-489B-AB76-95D4A43DB08AQ33215791-BD5C2300-7EA9-4A1A-81BB-76357860AA7EQ33220603-26DAC3B4-07F8-4ACE-BD88-2D9B5696F595Q33221829-46A37695-943A-4024-8C09-506DAB6ED31CQ33230149-145160ED-367F-464D-80B8-4F4942010392Q33231646-B129169C-9D32-4BE3-8AAC-0389FE3EA104Q33241474-E76A57E1-98FE-4925-8D10-1C1885EC753AQ33243117-FE104706-72A0-4004-8FE2-0A5D8FA4602FQ33251692-20E78629-7438-4F0C-AD63-CBB218863646Q33422818-7B90188D-46F7-4E6A-B2C7-491715F99FD9Q33538117-5999092C-0E23-442A-AEB9-C38A2D503757Q33619625-2A1D46BD-E9FF-4A08-8F76-32BD1570690AQ33764210-91ABCF7D-A847-4684-BE66-5F577759DF7BQ33798196-C6757516-84FC-43E6-91AC-50175FEFD473Q33805846-9FCCB255-1023-4DC7-AE55-E6DC95DECE57Q33925261-DDEEFCF2-3619-4DD5-9E74-EF43DAEAE933Q34153965-82455E78-6B29-4122-BD6C-93BDD4342A66Q34178690-7DD2AB25-7C4C-474E-AB9E-10820099E0D4Q34243335-94EDE9C8-B55B-49B6-B827-2248CF6925BAQ34314129-B7FBEE89-B716-4D90-B17D-D74EF733B4C3Q34499601-2A1CC7DA-1D6C-44D3-ADFA-A0D1F2BB85C6Q34507490-CCC149A2-11C9-41C4-8175-534BF8B42947Q34686995-C0987BB7-F1C9-46E7-A937-F6C5E38FB84CQ35022449-552DF323-EE99-4458-A53B-2048754D1A66Q35127370-B80FBA54-C698-4919-9B6E-81E54EDFEA21Q35432364-28F85180-8971-4D4D-B8D8-8C0193597E5EQ35518214-6DDE66EF-55E0-4EB7-850D-6A69EA811460
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Shotgun proteomics and biomarker discovery.
@ast
Shotgun proteomics and biomarker discovery.
@en
Shotgun proteomics and biomarker discovery.
@nl
type
label
Shotgun proteomics and biomarker discovery.
@ast
Shotgun proteomics and biomarker discovery.
@en
Shotgun proteomics and biomarker discovery.
@nl
prefLabel
Shotgun proteomics and biomarker discovery.
@ast
Shotgun proteomics and biomarker discovery.
@en
Shotgun proteomics and biomarker discovery.
@nl
P356
P1433
P1476
Shotgun proteomics and biomarker discovery
@en
P2093
John R Yates
P304
P356
10.1155/2002/505397
P577
2002-01-01T00:00:00Z